Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency and characterization of p53 mutations in clinically localized prostate cancer.

Urology - 1 Mar 1995

Hall M C, Navone N M, Troncoso P, Pollack A, Zagars G K, von Eschenbach A C, Conti C J, Chung L W

Abstract excerpt

OBJECTIVES: To determine the frequency of abnormal p53 expression and to characterize confirmed p53 mutations in tumors from patients with clinically localized adenocarcinoma of the prostate. METHODS: p53 protein nuclear accumulation was determined immunohistochemically in the initial diagnostic tumor specimens from 37 patients with clinically localized prostate carcinoma. Two primary antibodies were used on all...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genes, p53

Share to Molecular Sequence Data

Share to Mutation

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 7879337
DOI: 10.1016/s0090-4295(99)80018-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency and characterization of p53 mutations in clinically localized prostate cancer.PMID 7879337Read ↗

Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.Semantic proximity Read ↗

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.Semantic proximity Read ↗

Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.Semantic proximity Read ↗

Clinical significance of p53 alterations in surgically treated prostate cancers.Semantic proximity Read ↗

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerSemantic proximity Read ↗

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.Semantic proximity Read ↗

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.Semantic proximity Read ↗

p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.Semantic proximity Read ↗

Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53.Semantic proximity Read ↗

Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate CancerSemantic proximity Read ↗

p53 oncogene mutations in human prostate cancer specimens.Semantic proximity Read ↗

p53 gene alterations in human prostate carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.